American Century Companies Inc Eagle Pharmaceuticals, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$4.26 - $6.51 $50,498 - $77,169	11,854 Added 10.67%	123,002 $644,000
Q4 2023 Feb 13, 2024	BUY	$4.63 - $15.21 $514,615 - $1.69 Million	111,148 New	111,148 $581,000
Q3 2023 Nov 13, 2023	BUY	$15.21 - $22.88 $151,415 - $227,770	9,955 Added 11.26%	98,365 $1.55 Million
Q2 2023 Aug 14, 2023	BUY	$17.74 - $31.87 $386,944 - $695,148	21,812 Added 32.75%	88,410 $1.72 Million
Q1 2023 May 11, 2023	BUY	$25.06 - $34.09 $1.11 Million - $1.51 Million	44,241 Added 197.88%	66,598 $1.89 Million
Q4 2022 Feb 13, 2023	BUY	$24.98 - $39.77 $558,477 - $889,137	22,357 New	22,357 $653,000
Q1 2022 May 11, 2022	SELL	$44.58 - $52.6 $214,117 - $252,637	-4,803 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$45.82 - $56.9 $119,086 - $147,883	-2,599 Reduced 35.11%	4,803 $245,000
Q3 2021 Nov 10, 2021	BUY	$43.79 - $55.78 $324,133 - $412,883	7,402 New	7,402 $413,000
Q1 2021 May 14, 2021	SELL	$40.32 - $50.97 $494,605 - $625,248	-12,267 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$41.72 - $51.34 $1,501 - $1,848	36 Added 0.29%	12,267 $571,000
Q3 2020 Nov 13, 2020	SELL	$37.02 - $51.28 $99,694 - $138,097	-2,693 Reduced 18.04%	12,231 $520,000
Q2 2020 Aug 13, 2020	SELL	$43.24 - $55.02 $538,943 - $685,769	-12,464 Reduced 45.51%	14,924 $716,000
Q1 2020 May 14, 2020	BUY	$34.37 - $60.07 $139,267 - $243,403	4,052 Added 17.36%	27,388 $1.26 Million
Q4 2019 Feb 12, 2020	SELL	$54.32 - $64.31 $1.7 Million - $2.01 Million	-31,324 Reduced 57.31%	23,336 $1.4 Million
Q3 2019 Nov 13, 2019	BUY	$53.25 - $59.98 $30,192 - $34,008	567 Added 1.05%	54,660 $3.09 Million
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $2.52 Million - $3.16 Million	54,093 New	54,093 $3.01 Million
Q4 2018 Feb 13, 2019	SELL	$36.72 - $67.73 $118,054 - $217,751	-3,215 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$66.65 - $83.86 $214,279 - $269,609	3,215 New	3,215 $223,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account